SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-005907
Filing Date
2019-09-11
Accepted
2019-09-11 16:30:15
Documents
14
Period of Report
2019-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_091119.htm 6-K 11827
2 EXHIBIT 99.1 exh_991.htm EX-99.1 18200
3 GRAPHIC exh991_01.jpg GRAPHIC 68620
4 GRAPHIC exh991_02.jpg GRAPHIC 149757
5 GRAPHIC exh991_03.jpg GRAPHIC 67226
6 GRAPHIC exh991_04.jpg GRAPHIC 53246
7 GRAPHIC exh991_05.jpg GRAPHIC 77377
8 GRAPHIC exh991_06.jpg GRAPHIC 108267
9 GRAPHIC exh991_07.jpg GRAPHIC 92694
10 GRAPHIC exh991_08.jpg GRAPHIC 49999
11 GRAPHIC exh991_09.jpg GRAPHIC 62448
12 GRAPHIC exh991_10.jpg GRAPHIC 27431
13 GRAPHIC exh991_11.jpg GRAPHIC 13844
14 GRAPHIC exh991_12.jpg GRAPHIC 98411
  Complete submission text file 0001171843-19-005907.txt   1222184
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36686 | Film No.: 191088590
SIC: 2834 Pharmaceutical Preparations